This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

REPORT OF A GROUP OF DIABETIC PATIENTS IN WHOSE CASES GLYCOSURIA WAS DISREGARDED FOR ONE YEAR

EDWARD TOLSTOI, M.D.; FREDERICK C. WEBER, Jr., M.D.

Arch Intern Med. 1940;66(3):670-678.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The purpose of this communication is to present our observations on a group of diabetic patients who have been observed for a year or more during treatment with one daily dose of protamine zinc insulin. Furthermore, we plan to discuss briefly our routine therapy as well as to review the events which contributed to the adoption of the principles presented in this publication.

Protamine zinc insulin has been used in the treatment of diabetes mellitus for nearly four years. True, the original compound as prepared by Hagedorn¹ has undergone slight modifications, but basically the product is still regular insulin which has been mixed with protamine (a simple protein) with small quantities of zinc added to the compound. The resulting mixture, a milky suspension, is much less soluble, and is therefore more slowly absorbed in the subcutaneous tissues, than the clear soluble insulin hydrochloride discovered by Banting and Best.² . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the New York Hospital and the Department of Medicine, Cornell University Medical College.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?